Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvalYear |
2013
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
J07AH09
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:contains |
recombinant proteins
outer membrane vesicles |
| https://www.w3.org/2000/01/rdf-schema#label |
Bexsero
|
| gptkbp:indication |
individuals from 2 months of age and older
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
headache muscle pain injection site pain irritability |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:target |
gptkb:Neisseria_meningitidis_group_B
|
| gptkbp:usedFor |
prevention of meningococcal disease
|
| gptkbp:bfsParent |
gptkb:GSK
|
| gptkbp:bfsLayer |
6
|